Neurological deterioration as a potential alternative endpoint in human clinical trials of experimental pharmacological agents for treatment of severe traumatic brain injuries. Executive Committee of the International Selfotel Trial (Q39226174)
Jump to navigation
Jump to search
scientific article published on December 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Neurological deterioration as a potential alternative endpoint in human clinical trials of experimental pharmacological agents for treatment of severe traumatic brain injuries. Executive Committee of the International Selfotel Trial |
scientific article published on December 1998 |
Statements
1 reference
Neurological deterioration as a potential alternative endpoint in human clinical trials of experimental pharmacological agents for treatment of severe traumatic brain injuries. Executive Committee of the International Selfotel Trial (English)
1 reference
Morris GF
1 reference
Juul N
1 reference
Marshall SB
1 reference
Benedict B
1 reference
Marshall LF
1 reference
1 December 1998
1 reference
1 reference
1369-72; discussion 1372-4
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference